<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>Immune assist LDN - We love Iona - tribe.net</title>
  <link rel="alternate" href="http://ionaisthebomb.tribe.net/thread/bc49577e-5c16-4278-8ee4-14aa344661d5?format=atom" />
  <subtitle>Tribe.net. Local Connections</subtitle>
  <entry>
    <title>Immune assist LDN</title>
    <link rel="alternate" href="http://ionaisthebomb.tribe.net/thread/bc49577e-5c16-4278-8ee4-14aa344661d5#349fde93-3ed4-4b47-8ba3-5da65a7c0814" />
    <author>
      <name>iona</name>
    </author>
    <id>http://ionaisthebomb.tribe.net/thread/bc49577e-5c16-4278-8ee4-14aa344661d5#349fde93-3ed4-4b47-8ba3-5da65a7c0814</id>
    <updated>2007-02-06T01:23:28Z</updated>
    <published>2007-02-06T01:23:28Z</published>
    <summary type="html">http://www.lowdosenaltrexone.org/&#xD;
&#xD;
"LDN may well be the most important therapeutic breakthrough in over fifty years. It provides a new method of medical treatment by mobilizing the natural defenses of one's own immune system." — David Gluck, MD&#xD;
Low Dose Naltrexone&#xD;
&#xD;
FDA-approved naltrexone, in a low dose, can boost the immune system — helping those with HIV/AIDS, cancer, autoimmune diseases, and central nervous system disorders.&#xD;
&#xD;
First Study of LDN Published in US Medical Journal&#xD;
&#xD;
Dr. Jill Smith’s original article, "Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease," in the January issue of the American Journal of Gastroenterology (2007;102:1–9), officially presents LDN to the world of scientific medicine. Smith, Professor of Gastroenterology at Pennsylvania State University's College of Medicine, found that two-thirds of the patients in her pilot study went into remission and fully 89% of the group responded to treatment to some degree. She concluded that “LDN therapy appears effective and safe in subjects with active Crohn’s disease.”</summary>
    <dc:creator>iona</dc:creator>
    <dc:date>2007-02-06T01:23:28Z</dc:date>
  </entry>
</feed>



